Found 211 matching trials
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer PHASE1 This study will test whether vaccination with viagenpumatucel-L combined wi...
Show More Location
University of Arizona Cancer Center
Learn More & Join Trial
Study of NNZ-2566 in Patients With Traumatic Brain Injury PHASE2 The purpose of this study is to determine whether NNZ-2566 is safe and effe...
Show More Location
University of South Alabama
Learn More & Join Trial
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01) PHASE2 The main goals are after treatment given before surgery, to measure the num...
Show More Location
Southern Cancer Center (SCC) ( Site 8004)
Learn More & Join Trial
A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC PHASE3 This trial is a registrational phase III, randomized, open-label, multicent...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors PHASE1 This is an open-label, dose escalation and expansion study to evaluate the ...
Show More Location
UCSF Helen Diller Family Comprehensive Cancer Center
Learn More & Join Trial
Influence of Prior Chemotherapy on Clinical Benefit With Erlotinib in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With or Without EGFR Gene Mutation PHASE2 To compare the differential influence of 1st line doublet chemotherapy cont...
Show More Location
Chang Gung Memorial Hospital
Learn More & Join Trial
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)] PHASE2 An open-label, multicenter, phase II clinical study to evaluate the efficac...
Show More Location
Anhui Provincial Cancer Hospital
Learn More & Join Trial
LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer PHASE3 To compare the efficacy and safety of ceritinib with standard first-line ch...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Phase III Study of AK112 for NSCLC Patients PHASE3 A Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112...
Show More Status
Active Not Recruiting
Location
CBCC Global Research
Learn More & Join Trial
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions PHASE3 The purpose of this study is to compare the efficacy, as demonstrated by pr...
Show More Status
Active Not Recruiting
Learn More & Join Trial